Shipping velocity, deploy frequency, and project completion rates — the execution metrics that predict whether a company can deliver on its plan.
Strategy without execution is a PowerPoint presentation. In the context of M&A and PE investing, execution health — the ability of a company to consistently turn plans into shipped products, delivered services, and completed projects — is the single most deterministic factor in post-acquisition value creation. Yet traditional due diligence spends weeks analyzing the strategy and mere hours assessing execution capability.
The gap is understandable. Strategy is legible — it exists in documents, presentations, and financial models that can be reviewed and debated. Execution is emergent — it is the result of thousands of daily decisions, coordination events, and work outputs that do not consolidate neatly into a slide deck. Asking management "how well do you execute?" produces universally positive answers. Every company believes it executes well.
Behavioral data makes execution measurable. By analyzing the patterns of actual work output — deployment frequency, project completion rates, sprint velocity, calendar time allocation against stated priorities — you can build an objective picture of execution health that is independent of management self-assessment. Zoe's Delivery & Execution health dimension captures these patterns and benchmarks them against peer cohorts, producing a quantitative execution score that enables apples-to-apples comparison across investment opportunities.
The financial impact is direct. A Bain analysis of PE-backed companies found that top-quartile executors generate returns 2.5x higher than bottom-quartile executors, even when initial revenue growth rates are similar. Execution velocity compounds — a company that ships 12 product updates per quarter generates more market feedback, iterates faster, and captures more market share than a company shipping 3 updates per quarter. Over a 5-year hold period, this compounding effect can represent the difference between a 2x return and a 5x return.
Execution health is best measured through outcome metrics (what was delivered) and process metrics (how efficiently it was delivered). Behavioral metadata provides both.
Deployment frequency. For technology companies, the frequency of code deployments to production is the most direct measure of shipping velocity. Zoe analyzes GitHub and CI/CD metadata — commit frequency, pull request merge rates, deployment events — to measure how often the engineering team ships working software. Elite teams deploy multiple times per day. High performers deploy weekly. Low performers deploy monthly or less. The DORA (DevOps Research and Assessment) framework provides well-established benchmarks for these metrics.
Code review turnaround. The time between a pull request being opened and being reviewed, approved, and merged measures the responsiveness of the engineering team. Long review queues indicate either insufficient reviewer capacity, poor prioritization, or cultural reluctance to approve changes. Average review turnaround times exceeding 48 hours strongly correlate with declining engineering morale and impending attrition.
Sprint completion rate. By analyzing project management tool metadata (Jira, Linear, Asana, etc.), Zoe measures the percentage of planned work that is completed within its planned timeframe. Healthy teams complete 70-85% of planned sprint work. Teams below 50% are either consistently over-committing or facing execution barriers — both concerning patterns. The trend matters as much as the absolute number: a declining sprint completion rate indicates growing execution dysfunction.
Priority-activity alignment. One of the most revealing execution metrics is the alignment between stated priorities and actual time allocation. If a company says its top priority is launching a new product, but calendar data shows the product team spending 60% of their time in support escalation meetings and internal coordination, there is a fundamental execution gap. Zoe measures this alignment by comparing executive-stated priorities (from board decks and planning documents) against the actual distribution of team time across calendar events and communication patterns.
Unplanned work ratio. The percentage of team capacity consumed by unplanned work — bug fixes, firefighting, urgent customer requests, and ad hoc projects — is a critical execution health indicator. Healthy organizations maintain unplanned work below 20-25% of total capacity, preserving the majority of bandwidth for planned, strategic work. Companies with unplanned work ratios exceeding 40% are running on a treadmill — expending effort without forward progress.
Every company has plans. Roadmaps, OKRs, strategic initiatives, annual budgets — these artifacts describe what the organization intends to do. The execution gap is the distance between what was planned and what was actually delivered. A small execution gap indicates a disciplined, well-calibrated organization. A large gap indicates one or more systemic problems: poor planning (ambitions exceed capacity), weak prioritization (everything is important, so nothing is), or execution dysfunction (the team cannot convert plans into outputs).
Behavioral data quantifies the execution gap with precision. By comparing roadmap milestones against actual delivery dates, planned sprint velocity against actual sprint velocity, and stated strategic priorities against time allocation data, Zoe produces an Execution Gap Score that ranges from 0 (perfect alignment between plan and reality) to 100 (complete disconnection).
The most common drivers of execution gaps, as observed across Zoe's diagnostic database, include:
Coordination overhead. As organizations grow, the percentage of total effort spent on coordination (meetings, status updates, cross-team alignment) increases while the percentage spent on direct value creation (building, selling, serving customers) decreases. When coordination overhead exceeds 40% of total capacity, execution gaps widen rapidly. This is the fundamental challenge of scaling — the work of working together begins to crowd out the work itself.
Context switching. When individuals or teams are assigned to multiple concurrent projects, context switching destroys productive capacity. Research from the University of California, Irvine found that it takes an average of 23 minutes to fully regain focus after an interruption. Calendar data reveals context-switching patterns: individuals with frequent alternations between unrelated meeting topics, or with fewer than 2-hour blocks of unscheduled time, are operating in a fragmented mode that reduces effective output by 20-40%.
Decision bottlenecks feeding execution delays. This is where C-Suite and Delivery & Execution intersect. Slow decisions create execution stalls — teams waiting for direction, approval, or resource allocation. In Zoe's data, companies in the bottom quartile of decision velocity show execution gaps 2.3x larger than companies in the top quartile, even when team size and capability are similar.
Technical debt. For technology companies, accumulated technical debt — shortcuts taken in code, infrastructure, or architecture that create ongoing maintenance burden — directly reduces shipping velocity. Zoe detects technical debt indirectly through increasing bug fix ratios, elongating deployment cycle times, and a growing proportion of engineering time spent on maintenance versus new development.
Absolute execution metrics are meaningless without context. A 15-person startup should ship faster than a 300-person enterprise software company. A company in regulated healthcare will have longer deployment cycles than a consumer social app. Zoe benchmarks execution against peer cohorts defined by industry, company size, growth stage, and technology stack.
Key benchmark ranges from Zoe's diagnostic database:
Deployment frequency. B2B SaaS companies at the 50-200 employee stage: top quartile deploys 5+ times per week, median deploys 1-2 times per week, bottom quartile deploys less than twice per month. Companies below the bottom quartile threshold should be investigated for engineering process dysfunction, excessive technical debt, or insufficient engineering headcount.
Sprint completion rate. Across all technology companies: top quartile completes 80%+ of planned sprint work, median completes 65-75%, bottom quartile completes less than 55%. A consistently declining sprint completion rate — even if still within normal range — is a more concerning signal than a stable but moderate rate.
Time to first deployment for new hires. This metric captures how quickly new engineers become productive. Top-quartile companies see first production deployments within 2 weeks of hire start date. Bottom-quartile companies exceed 6 weeks. Slow onboarding to production correlates with poor documentation, complex development environments, and cultural resistance to junior contributions — all indicators of engineering organization health.
Planned vs. reactive work ratio. Healthy companies maintain at least a 70/30 split between planned and reactive work. Companies below 60/40 are in firefighting mode, and their ability to execute on strategic initiatives is structurally compromised. This metric is particularly important in due diligence because management presentations always focus on strategic plans — but if the team spends 45% of its time firefighting, those plans are aspirational at best.
Feature lead time. The elapsed time from when a feature is first spec'd to when it reaches production. For mid-market B2B SaaS, top-quartile companies deliver medium-complexity features in 2-4 weeks. Bottom-quartile companies take 8-12 weeks. Feature lead time captures the entire execution pipeline — planning, design, development, review, testing, deployment — and reflects the cumulative health of the execution system.
For PE firms focused on operational value creation, execution health represents one of the highest-ROI improvement areas. Unlike market expansion or product innovation, which depend on external factors and uncertain timelines, execution improvement is largely an internal exercise with well-understood interventions.
Reducing coordination overhead. Implementing asynchronous communication norms, reducing meeting load by 20-30%, and establishing clear RACI matrices for common decision types can recapture 10-15% of total team capacity for productive work. In a 100-person engineering organization, that translates to the equivalent of 10-15 additional engineers without any new hires.
Addressing technical debt strategically. Allocating 15-20% of engineering capacity to technical debt reduction — a practice that many companies know they should follow but defer under growth pressure — reduces maintenance burden and increases shipping velocity. The improvement typically takes 2-3 quarters to materialize but compounds over the hold period.
Implementing execution measurement. Many companies do not systematically track their own execution metrics. Simply implementing measurement — making deployment frequency, sprint completion rates, and feature lead times visible to the team — produces improvement through the Hawthorne effect. Teams that can see their own metrics tend to improve them.
Distributing execution authority. Centralizing execution decisions (product prioritization, sprint planning, resource allocation) at the executive level is a common pattern in founder-led companies. Distributing this authority to team leads — with clear guardrails and accountability — removes bottlenecks and increases overall throughput.
The typical improvement trajectory for a focused execution health initiative is a 25-40% improvement in shipping velocity within 6-9 months. For a technology company where product development velocity is the primary driver of competitive advantage, this improvement translates directly into revenue growth and market position — the core of the PE value creation thesis.
Execution health is not glamorous. It does not make for exciting board presentations or headline-worthy strategic pivots. But it is the fundamental determinant of whether a company can deliver on its plan — and therefore whether an acquisition will create or destroy value.
You have a deal on the table. Run a Zoe diagnostic before you sign.
Join 200+ firms on the waitlist
